PHA CanadaMay 13Sotatercept is now listed on Health Canada's websiteWe are pleased to announce that sotatercept, a new drug for patients diagnosed with pulmonary arterial hypertension (PAH), is now listed...
Dr. Sanjay MehtaMay 5Doctors need the right tools to treat patients well, especially for rare diseasesThis article originally appeared in The Hills Times on May 6, 2024 Have you ever tried to fix something without the right tool? If you...
PHA CanadaMay 5Dr. Jason Weatherald Discusses the Burden of PAH on the PHaware PodcastTune in to the latest episode of the PHaware podcast, where Dr. Jason Weatherald, a pulmonologist at the University of Alberta, delves...
PHA CanadaApr 21Disparities in BC's Public Drug PlanA recent report sheds light on the critical need for British Columbia to bolster its Public Drug Coverage. Over the past five years, BC...
PHA CanadaMar 26The FDA has granted approval for the medication sotaterceptThe US Food and Drug Administration (FDA) has granted approval for the medication sotatercept, a significant milestone in the treatment...
PHA CanadaMar 24Canada Disability Benefit UpdateOn June 22nd, 2023, a significant milestone was achieved as the federal government enacted Bill C-22, officially establishing the Canada...